Participating Hospitals

 

Study Overview and Summary

 Key Details

Chief Investigator:

Professor Colin Watts

Sponsor: 

University of Birmingham

Funder:

The Brain Tumour Charity

Disease Site: 

Glioma

Study Type:

Observational (Patient Registry)

Status:

Not yet recruiting

UKCRN Study ID:

44006

IRAS Number:

269228

ISRCTN:

 14218060

ClinialTrials.gov Number: 

 NCT04274283

Anticipated Recruitment Start Date:

01-Mar-2020

Anticipated Recruitment End Date: 

01-Mar-2025

CRCTU Trial Management Team: 

Early Drug Development Team

Study Email Adress:

BrainMatrix@trials.bham.ac.uk

Study Documents

Download all of the Study Documentation (password protected)